{
    "nctId": "NCT06418126",
    "briefTitle": "Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer",
    "officialTitle": "Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer : TNBC-RT2023",
    "overallStatus": "RECRUITING",
    "conditions": "Triple-negative Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 15,
    "primaryOutcomeMeasure": "Predictive value of recurrence associated with the appearance of inflammatory cytokines",
    "eligibilityCriteria": "Inclusion Criteria:\n\nWomen with TNBC breast cancer who meet the following criteria:\n\n* Women aged 18 and over;\n* Any tumor size (pT stage);\n* Regional lymph node pN0 to pN3;\n* Patient with pathologically confirmed TNBC (estrogen and progesterone receptor negative and HER2 negative);\n* Neo- or adjuvant chemotherapy followed by radiotherapy;\n* No evidence of distant metastasis at time of diagnosis;\n* Primary tumor removed by conservative surgery with negative margins;\n* Patient covered by the French social security system (for French patients).\n\nExclusion Criteria:\n\n* Distant metastasis at the time of diagnosis;\n* Pregnant or breast-feeding women;\n* Woman deprived of liberty, under guardianship or trusteeship.\n* Patient unable to give consent\n* Patient unable to speak French\n* Patients unable to undergo regular long-term surveillance.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}